Highlights:
- From the second week of June, Apollo Hospitals will begin administering the Russian COVID-19 vaccination Sputnik V.
- In the private sector, the group is the largest vaccinator.
- The group stated that they will continue to support the central and state governments in their efforts to combat the pandemic.
Apollo Hospitals said today that it will begin administering the Russian COVID-19 vaccination Sputnik V in the second week of June.
In India, Sputnik V, a Russian vaccine, is the third vaccination which has been approved after Covishield and Covaxin. The coronavirus vaccination is currently the country’s second most expensive Covid-19 shot.
The Apollo Group of Hospitals’ Executive Vice-Chairperson Shobana Kamineni announced in a statement that the group has completed administering one million vaccination doses across 80 locations in India, with frontline staff, high-risk groups, and corporate employees are on priority.
She explained how they want to increase their vaccination programme in the following way: “In June, we’ll do a million per week, and in July, we’ll double that. By September of this year, we should finish 20 million vaccinations.”
The group said it will continue to support the Union and State Governments in their fight against the pandemic as the largest vaccinator in the private sector.
“We appreciate the help of the Union and State governments, as well as the vaccine producers of Covishield and Covaxin,” Ms Kamineni said, adding that no one is safe until everyone has been vaccinated.
By September of this year, we should complete 20 million vaccinations.”
Also Read: Google Committed To Follow New Indian IT Rules, Says CEO Sundar Pichai
The Subject Expert Committee (SEC) has approved Sputnik V, a Russian vaccine for Covid-19, for Emergency Use Authorisation (EUA), making it the third COVID-19 vaccine to get clearance in India.
India has become the 60th country to approve the Sputnik V coronavirus vaccine developed by Russia. The vaccine has now been licenced in nations with a combined population of 3 billion people, accounting for 40% of the global population.
As of 8 a.m. on Thursday, the Ministry of Health and Family Welfare said that India has administered 20,26,95,874 vaccines.
To inoculate its population, India now uses primarily two “made in India” vaccines – Covishield from the Serum Institute and Covaxin from Bharat Biotech – as well as Russian-produced Sputnik V on a smaller scale, which has only been approved for people above the age of 18.
